The Scientist

» court, evolution and disease/medicine

Most Recent

image: Antibody Maker Headed to Court

Antibody Maker Headed to Court

By | February 17, 2014

The USDA claims that Santa Cruz Biotechnology, one of the biggest suppliers of antibodies for laboratory research, repeatedly violated the Animal Welfare Act.

6 Comments

image: Bodybuilders Take Breast Cancer Drug

Bodybuilders Take Breast Cancer Drug

By | February 17, 2014

Tamoxifen, an endocrine therapy for women with breast cancer, is found in a supplement marketed to bodybuilders.

0 Comments

image: Week in Review: February 10–14

Week in Review: February 10–14

By | February 14, 2014

First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism

0 Comments

image: Opinion: Reducing Whistleblower Risk

Opinion: Reducing Whistleblower Risk

By | February 11, 2014

It takes significant time and money for a scientist to defend his or her accusation of research misconduct.

5 Comments

image: Pesticide Linked to Alzheimer’s

Pesticide Linked to Alzheimer’s

By | February 10, 2014

Researchers find that DDT may increase the risk of the neurodegenerative disease.

0 Comments

image: Triglyceride Clock

Triglyceride Clock

By | February 10, 2014

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

0 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: Opinion: Confronting Creationism

Opinion: Confronting Creationism

By | February 7, 2014

Five reasons why scientists should stay out of debates over evolution.

55 Comments

image: Judges Side with FDA on Stem Cells

Judges Side with FDA on Stem Cells

By | February 6, 2014

A US federal appeals court maintains that stem cells proliferated in a lab must be regulated as a drug.

0 Comments

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. How to Tell a Person’s “Brain Age”
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS